Endothelium-derived relaxing factor

The Endothelium-derived relaxing factor (EDRF) is a strong vasodilator produced by cardiac endothelial cells in response to stress signals such as high levels of ADP accumulation or hypoxia.

[citation needed] Robert F. Furchgott is widely recognised for this discovery, even going so far as to be a co-recipient of the 1998 Nobel Prize in Medicine with his colleagues Louis J. Ignarro and Ferid Murad.

[citation needed] EDRF is produced from L-arginine by an enzyme (endothelial nitric oxide synthase) that is dependent on calcium-calmodulin and NADPH - this occurs in the cardiac endothelium.

[citation needed] EDRF then diffuses to the smooth muscle in vascular tissue (vessels may be large or small), here it enacts endogenous vasodilation.

[citation needed] The NO compound is also capable of reducing clotting in the blood stream due to its ability to prevent platelet adhesion and aggregation.

Nitric Oxide (NO), the principal EDRF
Anatomical cross section of an artery: the "intima" is composed of endothelial cells